5841 - 5850 of 8823 Results
Title
Year
-
OPENTitle: Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorderJournal Name: Clinical GeneticsPublisher: WileyVol: 102Issue #: 2Start Page: 98End Page: 109Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/cge.14165Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cge.14165Citation Count: 16
-
OPENTitle: Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathologyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 126End Page: 126Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00397-6Best OA location URL: https://www.nature.com/articles/s41531-022-00397-6.pdfCitation Count: 79
- [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease2022OPENTitle: [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 19Start Page: 3081End Page: 3081Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11193081Best OA location URL: https://www.mdpi.com/2073-4409/11/19/3081/pdf?version=1664531627Citation Count: 9
-
OPENTitle: Studying the Parkinson’s disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot studyJournal Name: Analytical and Bioanalytical ChemistryPublisher: Springer Science and Business Media LLCVol: 414Issue #: 25Start Page: 7399End Page: 7419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00216-022-04207-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00216-022-04207-z.pdfCitation Count: 35
- The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity2022OPENTitle: The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicityJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202010065Best OA location URL: https://escholarship.org/uc/item/4764f6j3Citation Count: 18
-
OPENTitle: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 11Start Page: e2121609119End Page: e2121609119Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2121609119Best OA location URL: https://escholarship.org/uc/item/4pt523rvCitation Count: 49
-
OPENTitle: Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease PatientsJournal Name: MetabolitesPublisher: MDPI AGVol: 12Issue #: 2Start Page: 149End Page: 149Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo12020149Best OA location URL: https://www.mdpi.com/2218-1989/12/2/149/pdf?version=1645608748Citation Count: 17
-
OPENTitle: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2112712119Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8892280Citation Count: 53
-
OPENTitle: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome ActivationJournal Name: International Journal of InflammationPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/2337363Best OA location URL: https://downloads.hindawi.com/journals/iji/2022/2337363.pdfCitation Count: 11
-
OPENTitle: Disease-Modifying Antirheumatic Drugs and Risk of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 12Start Page: e1273End Page: e1281Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013303Best OA location URL: https://n.neurology.org/content/neurology/98/12/e1273.full.pdfCitation Count: 23